Jupiter Neurosciences (JUNS) Financials: Revenue & Earnings
JUNS$2.39-0.11 -4.40%
$3.15M
Market Cap
—
P/E
—
Forward P/E
—
Score
Jupiter Neurosciences (JUNS) Financials: Revenue & Earnings
JUNS price $2.39 -0.11 -4.40%
- Ticker
- JUNS
- Price
- $2.39
- Change
- -0.11 -4.40%
- Market cap ?
- $3.15M
- Sector
- Healthcare
- Industry
- Biotechnology
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system…
Earnings and financials
Jupiter Neurosciences, Inc. (JUNS) trades at $2.39, with a market cap of $3.15M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn